Mbx Biosciences Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$43.03

+1.44 (+3.46%)

As of Jun 21, 10:06 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 1 6%

Sell 1 6%

Price Target

Analyst Price Target +9.5% upside

Low Target $32.34

Average Target $47.13

High Target $55.83

Current Price $43.03

Current
$43.03

Target
$47.13

$32.34 $47.13 avg $55.83

Scenario Analysis

Bear Case

$32.34

-24.8%

Low target

Base Case

$47.13

+9.5%

Avg target

Bull Case

$55.83

+29.7%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$45.85

-6.2% from high

52-Week Low

$9.43

+356.3% from low

Target vs 52W High

$47.13

+2.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+20.2%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+25.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+33.2%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+37.1%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+214.2%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+173.1%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-34.5%